CliffBio
small molecule

BREVIBLOC IN PLASTIC CONTAINER

ESMOLOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameBREVIBLOC IN PLASTIC CONTAINER
Active ingredientESMOLOL HYDROCHLORIDE
Strength1GM/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalFebruary 2001
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.